This Cannabis Stock Is Building Something Truly Special

The cannabis opportunity is too good to pass up, but not every stock will make you rich. Discover what makes Hexo Corp. (TSX:HEXO)(NYSE:HEXO) a winning bet.

| More on:

The cannabis opportunity is unlike any other. Multi-billion-dollar markets rarely appear virtually overnight. Both novice and veteran investors alike have the chance to get rich.

Just don’t assume that every cannabis stock will put you on the road to riches. Think back to the dot-com bubble of the 1990s. There were literally hundreds of internet stocks to invest in. Two decades later, the internet is larger than we ever imagined, but the vast majority of those former winners no longer exist. Often, investors lost everything.

Yet several of the most valuable companies in the world were launched during the bubble, including legendary stocks like Microsoft and Amazon.com. Pick the right stocks and financial independence can be yours.

Looking at the cannabis market today, you have plenty of investable options. Which stock should you trust with your money? If you want truly lucrative upside, there’s one clear choice.

Build something different

The cannabis market is growing fast. This we know. We also know that there’s a high probability that it will continue to grow for years, maybe even decades. Market demand has always spiked wherever marijuana has been made legal. With dozens of large markets — not to mention the biggest of all, the U.S. — still lacking federal legalization, the largest growth dominoes are yet to fall.

Yet as we saw with the dot-com bubble, being in a high-growth industry is no guarantee of success. The biggest hurdle that plagues cannabis companies is oversupply. Last year, I warned that commoditization was the biggest risk pot investors faced, even if few analysts were talking about it. This summer, Tilray helped tip off the cannabis bear market after it reported a big decline in selling prices.

Pricing pressure will only worsen. Nearly every cannabis producer still plans to ramp production further in 2020. If you want to succeed, you need to do more than grow pot.

Platforms will win

Earlier, I mentioned how Amazon and Microsoft were some of the only companies to not only survive the dot-com bubble but thrive in the years following it. What do they have in common? Both are platform companies.

Platform businesses allow other businesses to build on top of them. Application developers can build on top of Windows, while online merchants can build on top of Amazon’s marketplace. If you take away the underlying platforms, everything that is built on top disappears. That’s the power of platforms, enabling sky-high customer-retention rates and lucrative network effects.

Hexo (TSX:HEXO)(NYSE:HEXO) is applying the same approach to cannabis, something no other competitor is pursuing.

Instead of simply growing weed or packaging it to create its own brands, HEXO is building the base infrastructure for other businesses to build on top of. This year, it wrapped up construction of a grow facility, research and development centre, as well as a processing, packaging, and distribution facility. Other companies can then tap into this infrastructure to spin up their own cannabis products.

HEXO has already secured pilot partners. This month, its venture with Molson Coors Canada will launch its first cannabis-infused beverage. What’s more likely to succeed: a new Molson beverage or a beverage from an unknown pot startup? HEXO is betting on the former.

In 2020, HEXO is looking to secure additional partnerships in new verticals like cosmetics, sleep aids, and edibles. If it can validate its cannabis platform model, HEXO could easily become one of the best-performing pot stocks on the market. This is your chance to buy the Amazon and Microsoft of weed.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. David Gardner owns shares of Amazon. The Motley Fool owns shares of and recommends Amazon and Microsoft. The Motley Fool owns shares of Molson Coors Brewing. The Motley Fool recommends HEXO. and HEXO and recommends the following options: long January 2021 $85 calls on Microsoft. John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. David Gardner owns shares of Amazon. The Motley Fool owns shares of and recommends Amazon and Microsoft. The Motley Fool owns shares of Molson Coors Brewing. The Motley Fool recommends HEXO. and HEXO and recommends the following options: long January 2021 $85 calls on Microsoft. Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »